1. A PHASE 1 STUDY OF BET INHIBITION USING RG6146 IN RELAPSED/REFRACTORY (R/R) MYC‐EXPRESSING DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). (June 2017) Authors: Caimi, P.F.; Eder, J.P.; Jacobsen, E.D.; Jacobson, C.A.; LaCasce, A.S.; Shipp, M.A.; Chapuy, B.; Labriola‐Tomphins, E.; Boisserie, F.; Passe, S.; Chesné, E.; Pierceall, W.; Zhi, J.; DeMario, M.; Vaishampayan, U.; Dowlati, A.; Shapiro, G.I.; Fisher, D.C.; Armand, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B‐cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE‐170 phase 2 trial. (June 2017) Authors: Zinzani, P.; Thieblemont, C.; Melnichenko, V.; Osmanov, D.; Bouabdallah, K.; Walewski, J.; Majlis, A.; Fogliatto, L.; Caballero Barrigón, M.D.; Christian, B.; Gulbas, Z.; Özcan, M.; Salles, G.A.; Shipp, M.A.; Balakumaran, A.; Chlosta, S.; Chatterjee, A.; Armand, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. GIANNI BONADONNA MEMORIAL LECTURE: "GENETIC SIGNATURES AND TARGETABLE PATHWAYS IN LYMPHOID MALIGNANCIES". (June 2017) Authors: Shipp, M.A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PEMBROLIZUMAB MONOTHERAPY IN PATIENTS WITH PRIMARY REFRACTORY CLASSICAL HODGKIN LYMPHOMA: SUBGROUP ANALYSIS OF THE PHASE 2 KEYNOTE‐087 STUDY. (June 2017) Authors: Zinzani, P.L.; Fanale, M.A.; Chen, R.; Armand, P.; Johnson, N.; Brice, P.; Radford, J.; Ribrag, V.; Molin, D.; Vassilakopoulos, T.P.; Tomita, A.; von Tresckow, B.; Shipp, M.A.; Zhang, Y.; Balakumaran, A.; Moskowitz, C.H. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PHASE 1B STUDY OF PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (RRPMBCL): UPDATED RESULTS FROM THE KEYNOTE‐013 TRIAL. (June 2017) Authors: Zinzani, P.; Ribrag, V.; Moskowitz, C.H.; Michot, J.; Kuruvilla, J.; Bartlett, N.; Balakumaran, A.; Chatterjee, A.; Chlosta, S.; Shipp, M.A.; Armand, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗